This could possibly be explained by a greater increase in AST/ALT ratio in women relative to NAFLD-diagnosed men, predisposing women to an enhanced inflammatory response as the disease progresses and an increased risk for advanced fibrosis (20). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.